Therapeutic use and covid-19 in a pediatric population in Yaoundé
Authors/Creators
- 1. Department of Public Health. Faculty of Medicine and Biomedical Sciences. University of Yaounde I.
- 2. Department of Pediatrics. Faculty of Medicine and Biomedical Sciences. University of Yaounde I.
- 3. Department of Microbiology, Parasitology, Hematology and Infectious Diseases. Faculty of Medicine and Biomedical Sciences. University of Yaoundé I.
- 4. Department of Morphological Sciences and Anatomopathology. Faculty of Medicine and Biomedical Sciences. University of Yaoundé I.
- 5. Faculty of Medicine and Biomedical Sciences. University of Yaoundé I.
Description
Introduction: The COVID-19 pandemic is an airborne or hand borne viral respiratory disease. Its treatment is not yet totally codified.
Objective: The aim of this study was to describe the therapeutic remedies of COVID-19 in a paediatric population in Yaoundé.
Materials and methods: A cross sectional descriptive study was conducted in Nkolndongo health district from January to May 2021 for a duration of 5 months. All patients aged 0 to 19 years, tested COVID-19 by RT-PCR and managed in the Nkolndongo health district were included. Results were analysed using IBM SPSS.23.0 software and data expressed as frequencies and percentages.
Results: This study revealed that among the 48 patients tested positive 100%have received drugs as instructed by the national protocol 2020. The molecules involved included: introychloroquine, azithromycin, zinc and vitamin C. At the same time, 39.6% have received paracetamol and 4.16% have received oxygen. In addition of the national protocol drugs 43.75% have used Zingiber officinale and Citrus limon, 33.33% have used Cinchona officinalis, 25% have consumed Allium sativum, 22.92% Allium cepa, 8.33% honey, 6.25% Moringa oleifera and 10.41% mint crystals.
Conclusion: The treatment was according to the national COVID-19 protocol 2020. A high proportion of children has used traditional pharmacopoeia.